Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson’s disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs
Titel:
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson’s disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs
Auteur:
Pålhagen, Sven E. Sydow, Olof Johansson, Anders Nyholm, Dag Holmberg, Bjorn Widner, Hakan Dizdar, Nil Linder, Jan Hauge, Tove Jansson, Rasmus Bergmann, Lars Kjellander, Susanna Marshall, Thomas S.